Natural IgM prevents autoimmunity by enforcing B cell central tolerance induction

Journal of Immunology

Volumn 194, Issue 4, 2015, Pages 1489-1502

  Nguyen, Trang T T ^a   Elsner, Rebecca A ^a   Baumgarth, Nicole ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CD5 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN M; LEUKOSIALIN; PHOSPHATIDYLCHOLINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; B 1 CELL; B 1A CELL; B 2 CELL; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CELL SELECTION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRE B LYMPHOCYTE; SPLEEN; TURNOVER TIME; ANIMAL; AUTOIMMUNE DISEASE; C57BL MOUSE; CELL SEPARATION; CLONAL ANERGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; KNOCKOUT MOUSE; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CELL SEPARATION; CENTRAL TOLERANCE; CLONAL ANERGY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNE TOLERANCE; IMMUNOGLOBULIN M; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84922572798     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401880     Document Type: Article

References (58)

1. Ehrenstein, M. R., and C. A. Notley. 2010. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10: 778-786.
2. Hooijkaas, H., A. A. van der Linde-Preesman, S. Benne, and R. Benner. 1985. Frequency analysis of the antibody specificity repertoire of mitogen-reactive B cells and "spontaneously" occurring "background" plaque-forming cells in nude mice. Cell. Immunol. 92: 154-162.
3. Van Oudenaren, A., J. J. Haaijman, and R. Benner. 1984. Frequencies of background cytoplasmic Ig-containing cells in various lymphoid organs of athymic and euthymic mice as a function of age and immune status. Immunology 51: 735-742.
4. Choi, Y. S., J. A. Dieter, K. Rothaeusler, Z. Luo, and N. Baumgarth. 2012. B-1 cells in the bone marrow are a significant source of natural IgM. Eur. J. Immunol. 42: 120-129.
5. Benner, R., W. Hijmans, and J. J. Haaijman. 1981. The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin. Exp. Immunol. 46: 1-8.
6. Hayakawa, K., M. Asano, S. A. Shinton, M. Gui, D. Allman, C. L. Stewart, J. Silver, and R. R. Hardy. 1999. Positive selection of natural autoreactive B cells. Science 285: 113-116.
7. Berland, R., and H. H. Wortis. 2002. Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 20: 253-300.
8. Baumgarth, N., J. W. Tung, and L. A. Herzenberg. 2005. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 26: 347-362.
9. Vas, J., C. Grönwall, A. Marshak-Rothstein, and G. J. Silverman. 2012. Natural antibody to apoptotic cell membranes inhibits the proinflammatory properties of lupus autoantibody immune complexes. Arthritis Rheum. 64: 3388-3398.
10. Ogden, C. A., R. Kowalewski, Y. Peng, V. Montenegro, and K. B. Elkon. 2005. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity 38: 259-264.
11. Notley, C. A., M. A. Brown, G. P. Wright, and M. R. Ehrenstein. 2011. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J. Immunol. 186: 4967-4972.
12. Boes, M., T. Schmidt, K. Linkemann, B. C. Beaudette, A. Marshak-Rothstein, and J. Chen. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97: 1184-1189.
13. Alugupalli, K. R., R. M. Gerstein, J. Chen, E. Szomolanyi-Tsuda, R. T. Woodland, and J. M. Leong. 2003. The resolution of relapsing fever bor-reliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J. Immunol. 170: 3819-3827.
14. Haas, K. M., J. C. Poe, D. A. Steeber, and T. F. Tedder. 2005. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23: 7-18.
15. Martin, F., and J. F. Kearney. 2000. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol. Rev. 175: 70-79.
16. Cebra, J. J., J. L. Komisar, and P. A. Schweitzer. 1984. CH isotype "switching" during normal B-lymphocyte development. Annu. Rev. Immunol. 2: 493-548.
17. Victora, G. D., and M. C. Nussenzweig. 2012. Germinal centers. Annu. Rev. Immunol. 30: 429-457.
18. Louis, A. G., and S. Gupta. 2014. Primary selective IgM deficiency: an ignored immunodeficiency. Clin. Rev. Allergy Immunol. 46: 104-111.
19. Baumgarth, N., O. C. Herman, G. C. Jager, L. E. Brown, L. A. Herzenberg, and J. Chen. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192: 271-280.
20. Boes, M., A. P. Prodeus, T. Schmidt, M. C. Carroll, and J. Chen. 1998. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188: 2381-2386.
21. Choi, Y. S., and N. Baumgarth. 2008. Dual role for B-1a cells in immunity to influenza virus infection. J. Exp. Med. 205: 3053-3064.
22. Ochsenbein, A. F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R. M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159.
23. Ehrenstein, M. R., H. T. Cook, and M. S. Neuberger. 2000. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J. Exp. Med. 191: 1253-1258.
24. Rowley, B., L. Tang, S. Shinton, K. Hayakawa, and R. R. Hardy. 2007. Auto-reactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors. J. Autoimmun. 29: 236-245.
25. + (CD5) B cells that recognize phosphatidyl choline. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J. Exp. Med. 168: 687-698.
26. Erikson, J., M. Z. Radic, S. A. Camper, R. R. Hardy, C. Carmack, and M. Weigert. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349: 331-334.
27. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
28. Ota, T., C. Doyle-Cooper, A. B. Cooper, K. J. Doores, M. Aoki-Ota, K. Le, W. R. Schief, R. T. Wyatt, D. R. Burton, and D. Nemazee. 2013. B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates. J. Immunol. 191: 3179-3185.
29. Nemazee, D. A., and K. Bürki. 1989. Clonal deletion of B lymphocytes in a trans-genic mouse bearing anti-MHC class I antibody genes. Nature 337: 562-566.
30. Hardy, R. R., and K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19: 595-621.
31. von Boehmer, H., and F. Melchers. 2010. Checkpoints in lymphocyte development and autoimmune disease. Nat. Immunol. 11: 14-20.
32. Hippen, K. L., L. E. Tze, and T. W. Behrens. 2000. CD5 maintains tolerance in anergic B cells. J. Exp. Med. 191: 883-890.
33. Pillai, S., and A. Cariappa. 2009. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9: 767-777.
34. Casola, S., K. L. Otipoby, M. Alimzhanov, S. Humme, N. Uyttersprot, J. L. Kutok, M. C. Carroll, and K. Rajewsky. 2004. B cell receptor signal strength determines B cell fate. Nat. Immunol. 5: 317-327.
35. Kubagawa, H., S. Oka, Y. Kubagawa, I. Torii, E. Takayama, D. W. Kang, G. L. Gartland, L. F. Bertoli, H. Mori, H. Takatsu, et al. 2009. Identity of the elusive IgM Fc receptor (FcmuR) in humans. J. Exp. Med. 206: 2779-2793.
36. Shima, H., H. Takatsu, S. Fukuda, M. Ohmae, K. Hase, H. Kubagawa, J. Y. Wang, and H. Ohno. 2010. Identification of TOSO/FAIM3 as an Fc receptor for IgM. Int. Immunol. 22: 149-156.
37. Choi, S. C., H. Wang, L. Tian, Y. Murakami, D. M. Shin, F. Borrego, H. C. Morse, III, and J. E. Coligan. 2013. Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses. J. Immunol. 190: 987-996.
38. Ouchida, R., H. Mori, K. Hase, H. Takatsu, T. Kurosaki, T. Tokuhisa, H. Ohno, and J. Y. Wang. 2012. Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses. Proc. Natl. Acad. Sci. USA 109: E2699-E2706.
39. Baker, N., and M. R. Ehrenstein. 2002. Cutting edge: selection of B lymphocyte subsets is regulated by natural IgM. J. Immunol. 169: 6686-6690.
40. Boes, M., C. Esau, M. B. Fischer, T. Schmidt, M. Carroll, and J. Chen. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160: 4776-4787.
41. Rothaeusler, K., and N. Baumgarth. 2006. Evaluation of intranuclear BrdU detection procedures for use in multicolor flow cytometry. Cytometry A 69: 249-259.
42. Yamamoto, T., S. Takagawa, I. Katayama, K. Yamazaki, Y. Hamazaki, H. Shinkai, and K. Nishioka. 1999. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. J. Invest. Dermatol. 112: 456-462.
43. Fuxa, M., J. Skok, A. Souabni, G. Salvagiotto, E. Roldan, and M. Busslinger. 2004. Pax5 induces V-to-DJ rearrangements and locus contraction of the im-munoglobulin heavy-chain gene. Genes Dev. 18: 411-422.
44. Vieira, P., and K. Rajewsky. 1988. The half-lives of serum immunoglobulins in adult mice. Eur. J. Immunol. 18: 313-316.
45. Arnold, L. W., C. A. Pennell, S. K. McCray, and S. H. Clarke. 1994. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J. Exp. Med. 179: 1585-1595.
46. + B cells. Immunol. Rev. 197: 60-74.
47. Cambier, J. C., S. B. Gauld, K. T. Merrell, and B. J. Vilen. 2007. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. Immunol. 7: 633-643.
48. Notley, C. A., N. Baker, and M. R. Ehrenstein. 2010. Secreted IgM enhances B cell receptor signaling and promotes splenic but impairs peritoneal B cell survival. J. Immunol. 184: 3386-3393.
49. Honjo, K., Y. Kubagawa, D. M. Jones, B. Dizon, Z. Zhu, H. Ohno, S. Izui, J. F. Kearney, and H. Kubagawa. 2012. Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcmR). Proc. Natl. Acad. Sci. USA 109: 15882-15887.
50. Nguyen, X. H., P. A. Lang, K. S. Lang, D. Adam, G. Fattakhova, N. Föger, M. A. Kamal, P. Prilla, S. Mathieu, C. Wagner, et al. 2011. Toso regulates the balance between apoptotic and nonapoptotic death receptor signaling by facilitating RIP1 ubiquitination. Blood 118: 598-608.
51. Molina, H., V. M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93: 3357-3361.
52. Sakamoto, N., K. Shibuya, Y. Shimizu, K. Yotsumoto, T. Miyabayashi, S. Sakano, T. Tsuji, E. Nakayama, H. Nakauchi, and A. Shibuya. 2001. A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues. Eur. J. Immunol. 31: 1310-1316.
53. Honda, S., N. Kurita, A. Miyamoto, Y. Cho, K. Usui, K. Takeshita, S. Takahashi, T. Yasui, H. Kikutani, T. Kinoshita, et al. 2009. Enhanced humoral immune responses against T-independent antigens in Fca/mR-deficient mice. Proc. Natl. Acad. Sci. USA 106: 11230-11235.
54. Herzog, S., M. Reth, and H. Jumaa. 2009. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat. Rev. Immunol. 9: 195-205.
55. Kantor, A. B., and L. A. Herzenberg. 1993. Origin of murine B cell lineages. Annu. Rev. Immunol. 11: 501-538.
56. Deenen, G. J., and F. G. Kroese. 1992. Murine peritoneal Ly-1 B cells do not turn over rapidly. Ann. N. Y. Acad. Sci. 651: 70-71.
57. Wardemann, H., T. Boehm, N. Dear, and R. Carsetti. 2002. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J. Exp. Med. 195: 771-780.
58. Montecino-Rodriguez, E., and K. Dorshkind. 2012. B-1 B cell development in the fetus and adult. Immunity 36: 13-21.